Condition
Prion Diseases
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07732608Not Yet RecruitingPrimary
PROSPECT Registry for Individuals at Risk for Genetic Prion Disease
NCT05124392Recruiting
Biomarker Profiling in Individuals at Risk for Prion Disease
NCT02837705CompletedPrimary
Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
Showing all 3 trials